Here are the biggest calls on Wall Street on Wednesday:

Goldman Sachs reiterates Tesla as neutral

Goldman says it’s cautious on the company’s foray into semis.

“Tesla’s track record on semi engineering has been mixed in the past, with its Dojo team for AI training chips/compute having largely moved on from Tesla, but Tesla has been very successful with inference chips (and it sees a role for these chips stemming from its inference team to eventually be used in the data center and distributed computing applications too).”

Wells Fargo upgrades Kinetik, ONEOK and Enterprise Products Partners to overweight from equal weight

Wells upgraded several midstream companies and says they’re beneficiaries of the Iran war.

“The Iran war will create a structural shift in global energy mkts, boosting demand for US energy. We expect Permian gas/NGL [natural gas liquids] (& maybe oil) supply to accelerate to meet growing demand. Upgrading KNTK, EPD & OKE.”

Deutsche Bank initiates Esco Technologies as buy

Deutsche called the aerospace and defense company “defensive growth at a discount.”

“We are initiating coverage on ESCO Technologies with a Buy rating and $350 target price.”

Wolfe upgrades General Motors to outperform from peer perform

Wolfe says it sees “underappreciated” tailwinds.

“We upgrade GM to Outperform from Peer Perform, with a $96 target price. While 2026 could see small additional step-up in raw mats, investors may be underappreciating the magnitude of potential tailwinds into 2027.”

HSBC initiates Vertiv as buy

HSBC says the company is a “data center pure play.”

“Vertiv is a leading critical infrastructure provider for data centers and an important enabler of AI growth, with a full stack of solutions across the power and thermal management systems.”

Morgan Stanley initiates Immix Biopharma as overweight

Morgan Stanley says the biopharma company has plenty of upside.

“We initiate coverage of Immix Biopharma (IMMX) with an Overweight rating and $20 price target.”

Raymond James upgrades Arm to outperform from market perform

The firm upgraded the stock following the company’s in-house chip unveiling.

“We upgrade Arm to Outperform following the company’s announced business model shift to include a fabless semiconductor element. ... Arm has increased its forecast calling for FY28 earnings of $3 and FY31 reaching $9 a share. We establish a $166 target.”

Citigroup reiterates Amazon as buy

Citi raised its price target on Amazon to $285 per share from $265.

“We are raising our AWS projections given continued AI demand and our analysis of revenue contributions from Anthropic, OpenAI, and core (non-AI) workloads. We now project AWS revenue growth to be +28% Y/Y in 1Q26, +29% Y/Y for 2026E, and accelerate to +37% Y/Y in 2027E as its partnerships with Anthropic and OpenAI ramp.”

Goldman Sachs reiterates Braze as a top pick

Goldman says the stock is firing on all cylinders following earnings.

“We continue to view Braze as one of our top picks and believe they can sustain accelerated share gains as incumbent providers are burdened by legacy architectures and face challenges delivering on AI promises.”

Baird names Netflix a best idea

Baird says Netflix is well positioned.

“We expect execution throughout F26 to help restore investor confidence around the underlying drivers here – including the runway for monetization, the improvements in the member experience, and the increasingly global appeal of the offering. Beyond that, we think the stock is particularly well-positioned for the current environment, given the relative insulation from macro and AI concerns.”

Bank of America initiates Payoneer Global as buy

Bank of America says it sees a multitrillion dollar market opportunity for the financial services company.

“We initiate on Payoneer at Buy with a $6 PO and 27% upside.”

Baird reiterates Nike as outperform

The firm says negative investor sentiment is overdone.

“NKE has underperformed the market by -18% since the FQ2 report late December which we believe reflects recent negative sentiment for discretionary stocks (higher global oil prices) along with uncertainty tied to the state of NKE’s brand recovery across markets.”

UBS reiterates Microsoft as buy

UBS lowered its price target to $510 per share from $600 on Microsoft.

“At 19x CY26E non-GAAP EPS we remain Buy-rated, but acknowledge that the narrative around M365/Copilot needs to improve in order for the stock to really re-rate higher.”

Bank of America upgrades Acadia Pharmaceuticals to buy from neutral

The firm says the biopharma company has “pipeline potential.”

“We upgrade ACAD to Buy from Neutral.”

Rothschild & Co Redburn downgrades Mondelez to neutral from buy

Rothschild says it sees too many negative catalysts.

“Mondelēz faces numerous near-term threats: softening volumes and tougher competition in European chocolate, a sluggish US biscuit category that faces further pressure from changes to SNAP and slower growth in emerging markets.”